These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 29147908)
1. DJ-1 as a Biomarker of Parkinson's Disease. Saito Y Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908 [TBL] [Abstract][Full Text] [Related]
2. Oxidized DJ-1 as a possible biomarker of Parkinson's disease. Saito Y J Clin Biochem Nutr; 2014 May; 54(3):138-44. PubMed ID: 24894116 [TBL] [Abstract][Full Text] [Related]
3. Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients. Saito Y; Akazawa-Ogawa Y; Matsumura A; Saigoh K; Itoh S; Sutou K; Kobayashi M; Mita Y; Shichiri M; Hisahara S; Hara Y; Fujimura H; Takamatsu H; Hagihara Y; Yoshida Y; Hamakubo T; Kusunoki S; Shimohama S; Noguchi N Sci Rep; 2016 Jul; 6():30793. PubMed ID: 27470541 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Parkinson's disease and the level of oxidized DJ-1 protein. Yamagishi Y; Saigoh K; Saito Y; Ogawa I; Mitsui Y; Hamada Y; Samukawa M; Suzuki H; Kuwahara M; Hirano M; Noguchi N; Kusunoki S Neurosci Res; 2018 Mar; 128():58-62. PubMed ID: 28705587 [TBL] [Abstract][Full Text] [Related]
5. Distribution of oxidized DJ-1 in Parkinson's disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin. Mita Y; Kataoka Y; Saito Y; Kashi T; Hayashi K; Iwasaki A; Imanishi T; Miyasaka T; Noguchi N Sci Rep; 2018 Aug; 8(1):12056. PubMed ID: 30104666 [TBL] [Abstract][Full Text] [Related]
6. [The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease]. Ogawa I; Saito Y; Saigoh K; Hosoi Y; Mitsui Y; Noguchi N; Kusunoki S Brain Nerve; 2014 Apr; 66(4):471-7. PubMed ID: 24748095 [TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease-related DJ-1 modulates the expression of uncoupling protein 4 against oxidative stress. Xu S; Yang X; Qian Y; Xiao Q J Neurochem; 2018 May; 145(4):312-322. PubMed ID: 29315581 [TBL] [Abstract][Full Text] [Related]
8. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Saito Y; Hamakubo T; Yoshida Y; Ogawa Y; Hara Y; Fujimura H; Imai Y; Iwanari H; Mochizuki Y; Shichiri M; Nishio K; Kinumi T; Noguchi N; Kodama T; Niki E Neurosci Lett; 2009 Nov; 465(1):1-5. PubMed ID: 19733211 [TBL] [Abstract][Full Text] [Related]
9. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. Kahle PJ; Waak J; Gasser T Free Radic Biol Med; 2009 Nov; 47(10):1354-61. PubMed ID: 19686841 [TBL] [Abstract][Full Text] [Related]
10. Expression of DJ-1 in Neurodegenerative Disorders. Antipova D; Bandopadhyay R Adv Exp Med Biol; 2017; 1037():25-43. PubMed ID: 29147901 [TBL] [Abstract][Full Text] [Related]
11. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560 [TBL] [Abstract][Full Text] [Related]
12. Establishment of specific antibodies that recognize C106-oxidized DJ-1. Ooe H; Iguchi-Ariga SM; Ariga H Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058 [TBL] [Abstract][Full Text] [Related]
13. Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease. Kiss R; Zhu M; Jójárt B; Czajlik A; Solti K; Fórizs B; Nagy É; Zsila F; Beke-Somfai T; Tóth G Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2619-2629. PubMed ID: 28844983 [TBL] [Abstract][Full Text] [Related]
16. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Aleyasin H; Rousseaux MW; Phillips M; Kim RH; Bland RJ; Callaghan S; Slack RS; During MJ; Mak TW; Park DS Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18748-53. PubMed ID: 18003894 [TBL] [Abstract][Full Text] [Related]
17. The Multifaceted Roles of DJ-1 as an Antioxidant. Raninga PV; Di Trapani G; Tonissen KF Adv Exp Med Biol; 2017; 1037():67-87. PubMed ID: 29147904 [TBL] [Abstract][Full Text] [Related]
18. A transient post-translational modification of active site cysteine alters binding properties of the parkinsonism protein DJ-1. Mussakhmetov A; Shumilin IA; Nugmanova R; Shabalin IG; Baizhumanov T; Toibazar D; Khassenov B; Minor W; Utepbergenov D Biochem Biophys Res Commun; 2018 Sep; 504(1):328-333. PubMed ID: 30190129 [TBL] [Abstract][Full Text] [Related]
19. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease. Guo T; Zhou L; Xiong M; Xiong J; Huang J; Li Y; Zhang G; Chen G; Wang ZH; Xiao T; Hu D; Bao A; Zhang Z Aging Cell; 2024 May; 23(5):e14124. PubMed ID: 38380563 [TBL] [Abstract][Full Text] [Related]
20. PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target. Lind-Holm Mogensen F; Scafidi A; Poli A; Michelucci A J Neuroinflammation; 2023 Apr; 20(1):95. PubMed ID: 37072827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]